Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Entasis Therapeutics Holdings Inc. (ETTX) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Entasis Therapeutics Holdings Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1724344.
Total stock buying since 2018: $170,650,410.
Total stock sales since 2018: $360,915.
Total stock option exercises since 2018: $75,432.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 19,270,476 | $42,395,046 | 0 | $0 | 0 | $0 |
| 2021 | 10,000,000 | $20,000,000 | 34,770 | $110,915 | 0 | $0 |
| 2020 | 17,350,387 | $44,193,724 | 50,000 | $250,000 | 0 | $0 |
| 2018 | 4,270,776 | $64,061,640 | 0 | $0 | 22,024 | $75,432 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-07 | 19,270,476 | $42,395,046 | 0 | $0 | 0 | $0 |
| 2021-10 | 0 | $0 | 34,770 | $110,915 | 0 | $0 |
| 2021-06 | 6,268,975 | $12,537,950 | 0 | $0 | 0 | $0 |
| 2021-05 | 3,731,025 | $7,462,050 | 0 | $0 | 0 | $0 |
| 2020-09 | 4,672,897 | $12,499,999 | 0 | $0 | 0 | $0 |
| 2020-06 | 12,677,490 | $31,693,725 | 0 | $0 | 0 | $0 |
| 2020-01 | 0 | $0 | 50,000 | $250,000 | 0 | $0 |
| 2018-12 | 0 | $0 | 0 | $0 | 22,024 | $75,432 |
| 2018-09 | 4,270,776 | $64,061,640 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-07-11 | Innoviva Strategic Opportunities Llc | Buy | 7,598,814 | 2.20 | 16,717,390 |
| 2022-07-08 | Innoviva Strategic Opportunities Llc | Buy | 11,671,662 | 2.20 | 25,677,656 |
| 2021-10-19 | Ronsheim Matthew (See Remarks) | Sale | 3,759 | 3.19 | 11,991 |
| 2021-10-19 | Altarac David (Chief Medical Officer) | Sale | 3,759 | 3.19 | 11,991 |
| 2021-10-19 | Mueller John Patrick (Chief Development Officer) | Sale | 4,001 | 3.19 | 12,763 |
| 2021-10-19 | Perros Manoussos (See Remarks) | Sale | 11,974 | 3.19 | 38,197 |
| 2021-10-19 | Tommasi Ruben (Chief Scientific Officer) | Sale | 3,759 | 3.19 | 11,991 |
| 2021-10-19 | Gutch Michael (See Remarks) | Sale | 3,759 | 3.19 | 11,991 |
| 2021-10-19 | Keiley Elizabeth M (General Counsel) | Sale | 3,759 | 3.19 | 11,991 |
| 2021-06-11 | Innoviva Strategic Opportunities Llc | Buy | 6,268,975 | 2.00 | 12,537,950 |
| 2021-05-03 | Innoviva Strategic Opportunities Llc | Buy | 3,731,025 | 2.00 | 7,462,050 |
| 2020-09-01 | Innoviva, Inc. | Buy | 4,672,897 | 2.67 | 12,499,999 |
| 2020-06-11 | Innoviva, Inc. | Buy | 12,677,490 | 2.50 | 31,693,725 |
| 2020-01-09 | Heron Patrick J (10% Owner) | Sale | 50,000 | 5.00 | 250,000 |
| 2018-12-21 | Tommasi Ruben (Chief Scientific Officer) | Option Ex | 22,024 | 3.42 | 75,432 |
| 2018-09-28 | Pivotal Bioventure Partners Fund I U.g.p., Ltd (10% Owner) | Buy | 337,724 | 15.00 | 5,065,860 |
| 2018-09-28 | Fhm Life Sciences Viii, L.p. (10% Owner) | Buy | 375,887 | 15.00 | 5,638,305 |
| 2018-09-28 | Preston Heather (Director) | Buy | 337,724 | 15.00 | 5,065,860 |
| 2018-09-28 | Novo Holdings A/s (10% Owner) | Buy | 1,089,835 | 15.00 | 16,347,525 |
| 2018-09-28 | Topper James N (Director) | Buy | 375,887 | 15.00 | 5,638,305 |
| 2018-09-28 | Wheeler Kurt (10% Owner) | Buy | 453,395 | 15.00 | 6,800,925 |
| 2018-09-28 | Galakatos Nicholas (Director) | Buy | 453,395 | 15.00 | 6,800,925 |
| 2018-09-28 | Powell Michael (10% Owner) | Buy | 337,724 | 15.00 | 5,065,860 |
| 2018-09-28 | Coulter James G | Buy | 262,539 | 15.00 | 3,938,085 |
| 2018-09-28 | Astrazeneca Ab (10% Owner) | Buy | 246,666 | 15.00 | 3,699,990 |
Insider trading activities including stock purchases, stock sales, and option exercises of ETTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Entasis Therapeutics Holdings Inc. (symbol ETTX, CIK number 1724344) see the Securities and Exchange Commission (SEC) website.